MorphoSys AG ADR Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. MorphoSys AG ADR last-minute Real Value cannot be determined due to lack of data. The latest price of MorphoSys AG ADR is $0.0. Our model forecasts the value of MorphoSys AG ADR from analyzing the firm fundamentals such as Return On Equity of -1.84, current valuation of 2.68 B, and Profit Margin of (1.91) % as well as examining its technical indicators and probability of bankruptcy.

MorphoSys Total Value Analysis

MorphoSys AG ADR is now estimated to have company total value of 2.68 B with market capitalization of 2.86 B, debt of 635.93 M, and cash on hands of 726.83 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the MorphoSys fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
2.68 B
2.86 B
635.93 M
726.83 M

MorphoSys Investor Information

The company recorded a loss per share of 1.5. MorphoSys AG ADR had not issued any dividends in recent years. Based on the key indicators related to MorphoSys' liquidity, profitability, solvency, and operating efficiency, MorphoSys AG ADR is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

MorphoSys Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MorphoSys has an asset utilization ratio of 11.76 percent. This connotes that the Company is making $0.12 for each dollar of assets. An increasing asset utilization means that MorphoSys AG ADR is more efficient with each dollar of assets it utilizes for everyday operations.

MorphoSys Ownership Allocation

MorphoSys AG ADR maintains a total of 150.65 Million outstanding shares. Roughly 92.56 % of MorphoSys outstanding shares are held by general public with 7.44 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Public92.56%I...7.44%100%

MorphoSys Profitability Analysis

The company reported the last year's revenue of 238.28 M. Reported Net Loss for the year was (189.73 M) with profit before taxes, overhead, and interest of 229.65 M.
238.3M229.6M-97.7M-189.7M-1.0B100%

MorphoSys Growth Indicators

Investing in growth stocks can be very risky. If the company such as MorphoSys does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding137.3 M
Quarterly Earnings Growth Y O Y-0.874
Forward Price Earnings322.5806
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in MorphoSys Stock

If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance

Trending Assets

IMRX
Immuneering Corp
1.86  0.04  2.20 
ACLX
Arcellx
65.23  1.52  2.39 
PCVX
Vaxcyte
84.00  0.16  0.19 
VTYX
Ventyx Biosciences
1.71  0.03  1.79